Latest News and Press Releases
Want to stay updated on the latest news?
-
WALTHAM, Mass., July 12, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation announced today that it has...
-
Two Agreements Year to Date to Incorporate PerioPredict® into Employee Benefit Plans Conference call today at 8:30 AM Eastern Standard time WALTHAM, Mass., May 16, 2016 (GLOBE NEWSWIRE) --...
-
WALTHAM, Mass., May 10, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it will host a conference call and webcast on Monday, May 16, 2016, at 8:30 a.m. Eastern...
-
WALTHAM, Mass., May 04, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic...
-
WALTHAM, Mass., April 26, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic...
-
WALTHAM, Mass., April 21, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic...
-
WALTHAM, Mass., April 05, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic...
-
WALTHAM, Mass., March 29, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic...
-
Progress in Executing Commercial Plan Underscored by Recent Agreement with Metagenics, Inc. Conference Call and Webcast Today at 8:30 a.m. EDT WALTHAM, Mass., March 17, 2016 (GLOBE...
-
WALTHAM, Mass., March 16, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic...